Jonathan Hensel, PhD

Quorum Innovations
Sarasota, Florida, United States

Disclosure information not submitted.

Presentation(s):

• Paper 33 - A PHASE I TRIAL OF LYMPHODEPLETION PLUS ADOPTIVE CELL THERAPY WITH TUMOR INFILTRATING LYMPHOCYTES FOLLOWED BY HIGH-DOSE IL-2 IN ADOLESCENT AND YOUNG ADULT PATIENTS WITH SOFT TISSUE SARCOMA

  Friday, November 3, 2023
  9:00 AM – 10:00 AM